TriSalus Life Sciences In... (TLSI)
NASDAQ: TLSI
· Real-Time Price · USD
4.62
0.10 (2.21%)
At close: Oct 03, 2025, 3:59 PM
4.70
1.73%
After-hours: Oct 03, 2025, 07:53 PM EDT
2.21% (1D)
| Bid | 3.33 |
| Market Cap | 175.45M |
| Revenue (ttm) | 35.99M |
| Net Income (ttm) | -31.17M |
| EPS (ttm) | -1.13 |
| PE Ratio (ttm) | -4.09 |
| Forward PE | -45.2 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 4.7 |
| Volume | 93,658 |
| Avg. Volume (20D) | 94,096 |
| Open | 4.57 |
| Previous Close | 4.52 |
| Day's Range | 4.43 - 4.67 |
| 52-Week Range | 3.42 - 5.88 |
| Beta | 0.47 |
| Ex-Dividend Date | n/a |
About TLSI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TLSI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TLSI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsTriSalus Life Sciences Inc. is scheduled to release its earnings on
Nov 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
10 months ago
-10.89%
TriSalus Life Sciences shares are trading lower af...
Unlock content with
Pro Subscription
1 month ago · seekingalpha.com
TriSalus Life Sciences, Inc. (TLSI) Q2 2025 Earnings Call TranscriptTriSalus Life Sciences, Inc. (NASDAQ:TLSI ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 AM ET Company Participants David B. Patience - Chief Financial Officer Jeremy Feffer - Corporate Parti...
2 months ago · businesswire.com
TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference CallWESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), a company working to improve outcomes for patients with solid tumors by combining innova...
